GoodRx Holdings, Inc. GDRX Prescription reimbursement liabilities
Prescription reimbursement liabilities at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept gdrx:IncreaseDecreaseInPrescriptionReimbursableLiabilities.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s prescription reimbursement liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s prescription reimbursement liabilities?
- GoodRx Holdings, Inc. (GDRX) reported prescription reimbursement liabilities of $620.84M in Q1 2026.
- How has GoodRx Holdings, Inc.'s prescription reimbursement liabilities changed year-over-year?
- GoodRx Holdings, Inc.'s prescription reimbursement liabilities increased by 7386.8% year-over-year, from -$8.52M to $620.84M.
- What does prescription reimbursement liabilities mean?
- This represents the net change in liabilities owed to pharmacies or other service providers for prescription-related services that have been incurred but not yet settled. It serves as a measure of the company's short-term obligations to its network partners and the impact of payment cycle timing on working capital.